LORI MIKNAITIS: Open Payments
NPI 1326673575 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,061 in 26 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,061
Food & beverage: $1,061
| Company | Payments | Amount |
|---|---|---|
| Spinal Simplicity, LLC | 4 | $495 |
| ARGENX US, INC. | 3 | $162 |
| Lundbeck LLC | 3 | $66 |
| UCB, Inc. | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Novartis Pharmaceuticals Corporation | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Grifols USA, LLC | 1 | $26 |
| Janssen Biotech, Inc. | 1 | $25 |
| CSL Behring | 1 | $21 |
Products named: HA MINUTEMAN G3-R, VYVGART, REXULTI, HYQVIA, KESIMPTA, VYVGART HYTRULO, Fintepla, Gamunex-C.
Industry payments across LA — which companies pay providers there.
